Arnold S Bayer1, Nagendra N Mishra1, Ambrose L Cheung2, Aileen Rubio3, Soo-Jin Yang4. 1. Division of Infectious Diseases, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA The David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. 2. Department of Microbiology, Geisel School of Medicine at Dartmouth, Hanover, NH, USA. 3. Spero Therapeutics, Cambridge, MA, USA. 4. School of Bioresources and Bioscience, Chung-Ang University, 4726 Seodong-daero, Daedeok-myeon, Anseong-si, Gyeonggi-do 456-756, Republic of Korea soojin@cau.ac.kr.
Abstract
BACKGROUND: In small series or individual reports, SNPs within the mprF ORF and dysregulation of its expression in Staphylococcus aureus have been linked to daptomycin resistance (DAP-R) via a proposed gain-in-function mechanism. Similarly, dysregulation of dltABCD has also been associated with DAP-R. METHODS: Using 22 well-characterized, isogenic daptomycin-susceptible (DAP-S)/DAP-R clinical MRSA strain pairs, we assessed potential relationships of the DAP-R phenotype with: (i) regulation of mprF transcription; (ii) regulation of dltABCD transcription; (iii) expression of the two-component regulatory system, graRS (upstream regulator for both mprF and dltABCD transcription); (iv) SNPs within the graRS promoter or its ORF; and (v) altered mprF transcription and lysyl-phosphatidylglycerol (L-PG) synthesis. RESULTS: Enhanced expression of mprF occurred with SNPs in highly distinct and well-chronicled MprF domain 'hot spots' and rarely occurred without such mutations. Increased expression and/or dysregulation of mprF and dltABCD were not uncommon in DAP-R strains, occurring in 27% of strains for each gene. In these latter strains, neither graRS expression profiles nor polymorphic sequences within the graRS promoter or ORF could be significantly linked to altered transcription of mprF or dlt. CONCLUSIONS: Although graRS can co-regulate mprF and dltABCD expression, loci outside of this regulon appear to be involved in dysregulation of these latter two genes and the DAP-R phenotype. Finally, DAP-R strains exhibiting significantly altered mprF transcription profiles produced significantly increased levels of L-PG.
BACKGROUND: In small series or individual reports, SNPs within the mprF ORF and dysregulation of its expression in Staphylococcus aureus have been linked to daptomycin resistance (DAP-R) via a proposed gain-in-function mechanism. Similarly, dysregulation of dltABCD has also been associated with DAP-R. METHODS: Using 22 well-characterized, isogenic daptomycin-susceptible (DAP-S)/DAP-R clinical MRSA strain pairs, we assessed potential relationships of the DAP-R phenotype with: (i) regulation of mprF transcription; (ii) regulation of dltABCD transcription; (iii) expression of the two-component regulatory system, graRS (upstream regulator for both mprF and dltABCD transcription); (iv) SNPs within the graRS promoter or its ORF; and (v) altered mprF transcription and lysyl-phosphatidylglycerol (L-PG) synthesis. RESULTS: Enhanced expression of mprF occurred with SNPs in highly distinct and well-chronicled MprF domain 'hot spots' and rarely occurred without such mutations. Increased expression and/or dysregulation of mprF and dltABCD were not uncommon in DAP-R strains, occurring in 27% of strains for each gene. In these latter strains, neither graRS expression profiles nor polymorphic sequences within the graRS promoter or ORF could be significantly linked to altered transcription of mprF or dlt. CONCLUSIONS: Although graRS can co-regulate mprF and dltABCD expression, loci outside of this regulon appear to be involved in dysregulation of these latter two genes and the DAP-R phenotype. Finally, DAP-R strains exhibiting significantly altered mprF transcription profiles produced significantly increased levels of L-PG.
Authors: Christopher Weidenmaier; Andreas Peschel; Volkhard A J Kempf; Natalie Lucindo; Michael R Yeaman; Arnold S Bayer Journal: Infect Immun Date: 2005-12 Impact factor: 3.441
Authors: Soo-Jin Yang; Arnold S Bayer; Nagendra N Mishra; Michael Meehl; Nagender Ledala; Michael R Yeaman; Yan Q Xiong; Ambrose L Cheung Journal: Infect Immun Date: 2011-10-10 Impact factor: 3.441
Authors: Kasturi Mukhopadhyay; William Whitmire; Yan Q Xiong; Jaime Molden; Tiffanny Jones; Andreas Peschel; Petra Staubitz; Jill Adler-Moore; Peter J McNamara; Richard A Proctor; Michael R Yeaman; Arnold S Bayer Journal: Microbiology Date: 2007-04 Impact factor: 2.777
Authors: Soo-Jin Yang; Yan Q Xiong; Paul M Dunman; Jacques Schrenzel; Patrice François; Andreas Peschel; Arnold S Bayer Journal: Antimicrob Agents Chemother Date: 2009-03-16 Impact factor: 5.191
Authors: Arnold S Bayer; Nagendra N Mishra; Liang Chen; Barry N Kreiswirth; Aileen Rubio; Soo-Jin Yang Journal: Antimicrob Agents Chemother Date: 2015-06-08 Impact factor: 5.191
Authors: Arnold S Bayer; Nagendra N Mishra; George Sakoulas; Poochit Nonejuie; Cynthia C Nast; Joseph Pogliano; Kuan-Tsen Chen; Steven N Ellison; Michael R Yeaman; Soo-Jin Yang Journal: Antimicrob Agents Chemother Date: 2014-10-06 Impact factor: 5.191
Authors: Ambrose L Cheung; Arnold S Bayer; Michael R Yeaman; Yan Q Xiong; Alan J Waring; Guido Memmi; Niles Donegan; Siyang Chaili; Soo-Jin Yang Journal: Infect Immun Date: 2014-10-06 Impact factor: 3.441
Authors: Nagendra N Mishra; Soo-Jin Yang; Ayumi Sawa; Aileen Rubio; Cynthia C Nast; Michael R Yeaman; Arnold S Bayer Journal: Antimicrob Agents Chemother Date: 2009-03-30 Impact factor: 5.191
Authors: Christoph M Ernst; Petra Staubitz; Nagendra N Mishra; Soo-Jin Yang; Gabriele Hornig; Hubert Kalbacher; Arnold S Bayer; Dirk Kraus; Andreas Peschel Journal: PLoS Pathog Date: 2009-11-13 Impact factor: 6.823
Authors: Rachel E Jenson; Sarah L Baines; Benjamin P Howden; Nagendra N Mishra; Sabrina Farah; Cassandra Lew; Andrew D Berti; Sanjay K Shukla; Arnold S Bayer; Warren E Rose Journal: Antimicrob Agents Chemother Date: 2020-08-20 Impact factor: 5.191
Authors: A Renzoni; E Von Dach; C Landelle; S M Diene; C Manzano; R Gonzales; W Abdelhady; C P Randall; E J Bonetti; D Baud; A J O'Neill; A Bayer; A Cherkaoui; J Schrenzel; S Harbarth; P François Journal: Antimicrob Agents Chemother Date: 2017-09-22 Impact factor: 5.191
Authors: Kyoung-Mi Kang; Nagendra N Mishra; Kun Taek Park; Gi-Yong Lee; Yong Ho Park; Arnold S Bayer; Soo-Jin Yang Journal: J Microbiol Date: 2017-01-26 Impact factor: 3.422
Authors: Zhuo Ma; Erica Lasek-Nesselquist; Jackson Lu; Ryan Schneider; Riddhi Shah; George Oliva; Janice Pata; Kathleen McDonough; Manjunath P Pai; Warren E Rose; George Sakoulas; Meenakshi Malik Journal: PLoS One Date: 2018-06-07 Impact factor: 3.240
Authors: Christoph M Ernst; Christoph J Slavetinsky; Sebastian Kuhn; Janna N Hauser; Mulugeta Nega; Nagendra N Mishra; Cordula Gekeler; Arnold S Bayer; Andreas Peschel Journal: mBio Date: 2018-12-18 Impact factor: 7.867
Authors: Nagendra N Mishra; Arnold S Bayer; Sarah L Baines; Ashleigh S Hayes; Benjamin P Howden; Christian K Lapitan; Cassandra Lew; Warren E Rose Journal: Microorganisms Date: 2021-05-11
Authors: Nicholas K Goldner; Christopher Bulow; Kevin Cho; Meghan Wallace; Fong-Fu Hsu; Gary J Patti; C A Burnham; Paul Schlesinger; Gautam Dantas Journal: mSphere Date: 2018-08-08 Impact factor: 4.389